TASI 8030 · Insurance · MEDGULF
Statement of Changes in Equity
9M / Q3 2023Equity movements
| Movement | Total equitySAR thousands |
|---|---|
| 2023 equity movements | |
| Balance at 31 December 2022 as previously reported | 645,060 |
| Transition adjustment on application of IFRS 17 and IFRS 9Note 4 | 61,658 |
| Restated balance at 1 January 2023 | 706,718 |
| Net income (loss) for the period | 140,560 |
| Change in fair value of investments | (6,546) |
| Balance at 2023-09-30 | 840,732 |
| 2022 equity movements | |
| Balance at 31 December 2021 as previously reported | 1,014,649 |
| Transition adjustment on application of IFRS 17 and IFRS 9Note 4 | 96,096 |
| Restated balance at 1 January 2022 | 1,110,745 |
| Net income (loss) for the period | (173,673) |
| Balance at 2022-09-30 | 937,072 |